51655-0809 Ondansetron

Product NDC:

51655-0809

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 8.0

Unit: mg/1

Packages:

Code: 51655-0809-53

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-809-53)

Effective Date: May 6, 2022

Discontinued:

Code: 51655-0809-87

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-809-87)

Effective Date: Nov. 30, 2020

Discontinued:

Code: 51655-0809-04

Description: 4 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-809-04)

Effective Date: Nov. 7, 2022

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox